Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Characterization of Neurological Outcome in Vasculitic Neuropathy

Author:Rakhmonova, Sevinch   Karam, Chafic   

Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Autoimmune Neuropathies  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P1.011  

Author Institution:University of Pennsylvania, Philadelphia, PA  University of Pennsylvania, PA  

End-of-Life Care in Neurodegenerative Diseases: Assessment and Perspectives for Community Pharmacist Involvement

Author:Auffret, Manon   Conty, Céline   Keromnes, Jeanne   Verin, Marc   

Session Name:P1: Palliative Care  

Topic:Palliative Care  

Program Number:P1.011  

Author Institution:FDE /CHU Rennes - Université de Rennes, Lamballe, France  Université de Rennes, France, Metropolitan  Community Pharmacy, France  CHU Orléans, Rennes, France  

Spinal Cord Stroke in an Adult Following Chimeric Antigen Receptor-T Cell Therapy for B Cell Acute Lymphoblastic Leukemia

Author:Buyukkurt, Asli   Pardo-Villamizar, Carlos   

Session Name:P1: Cerebrovascular Disease and Interventional Neurology: Rare Clinical Case Presentations  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P1.011  

Author Institution:Johns Hopkins University, Baltimore, MD  

An Immunocompromised Individual Presenting with two Unlikely Combinations: An Infectious and Autoimmune Disease

Author:Ho, Marjorie   Gali, Harini   Choi, Seulgi   

Session Name:P1: Infectious Disease: HIV 1  

Topic:Infectious Disease  

Program Number:P1.011  

Author Institution:Texas Tech University Health Sciences Center, Lubbock, TX  Texas Tech University Health Science Center, Lubbock, TX  

First in Class ASO Targeting SNCA p.A53T Allele: Preclinical Efficacy

Author:Tyner, Christina   Smieszek, Sandra   Przychodzen, Bart   Apokotou, Olympia   Papastefanaki, Florentia   Polymeropoulos, Christos   Birznieks, Gunther   Taoufik, Era   Polymeropoulos, Mihael   

Session Name:P1: Movement Disorders: Parkinson's Disease Genetics, Biomarkers, and Basic Science 1  

Topic:Movement Disorders  

Program Number:P1.011  

Author Institution:Vanda Pharmaceuticals Inc., Washington, DC  Laboratory of Cellular and Molecular Neurobiology, Hellenic Pasteur Institute, Athens, Greece